Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
National Health Service
MedTech
Grail makes ground in massive U.S., U.K. clinical studies
Grail, now split from Illumina, is nearing the finish line in its 140,000-participant NHS study, while enrolling over 35,000 patients in the U.S.
Conor Hale
Jul 17, 2024 10:29am
Former health minister appointed to review UK clinical trials
Feb 23, 2023 7:20am
NHS-backed AI company Sensyne raises cash, pens Phesi pact
Dec 9, 2020 7:28am
Roche’s supply snags hit COVID-19 testing in the U.K.: Reuters
Oct 7, 2020 9:25am
Amazon's Alexa to offer NHS health advice in new app
Jul 12, 2019 9:05am
Distrust is frustrating U.K. NHS-industry cooperation: report
Jun 19, 2019 9:30am
